Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Shoji

Showing results (81-90 of 109) with videos related to

Pageof 11
Sort By:
American Journal of Preventive Cardiology|January 29, 2025
Achievement of guideline-based lipid goals among very-high-risk patients with atherosclerotic cardiovascular disease and type 2 diabetes: results in 213,380 individuals from the cvMOBIUS2 registrySatoshi Shoji, Nishant P Shah, Peter Shrader, et al.
JAMA Network Open|January 14, 2025
Electronic Patient-Reported Outcome System Implementation in Outpatient Cardiovascular Care: A Randomized Clinical TrialShuhei Yamashita, Yoshinori Katsumata, Shun Kohsaka, et al.
Oncology|February 15, 2018
A Phase II Study of Irinotecan for Patients with Previously Treated Small-Cell Lung CancerRie Kondo, Satoshi Watanabe, Satoshi Shoji, et al.
European Journal of Heart Failure|July 4, 2025
Residual pulmonary hypertension and clinical outcomes in acute decompensated heart failure patients stratified by left ventricular ejection fractionToshikazu D Tanaka, Yasuyuki Shiraishi, Ryeonshi Kang, et al.
International Journal of Cardiology|April 14, 2022
Conventional medical therapy in heart failure patients eligible for the PARADIGM-HF, DAPA-HF, and SHIFT trialsSatoshi Shoji, Shun Kohsaka, Yasuyuki Shiraishi, et al.
Circulation. Heart Failure|January 26, 2018
Percutaneous Occlusion of Patent Ductus Arteriosus for an Elderly Patient With Refractory Congestive Heart FailureSatoshi Shoji, Hideaki Kanazawa, Ryo Yanagisawa, et al.
Journal of Atherosclerosis and Thrombosis|March 4, 2026
Cardiovascular Risk of Alcohol Consumption due to Renal Impairment: A 10-Year Prospective Study in a Community-Dwelling Japanese PopulationAya Hirata, Sei Harada, Miho Iida, et al.
Translational Lung Cancer Research|October 17, 2022
Efficacy and safety of amrubicin therapy after chemoimmunotherapy in small cell lung cancer patientsKohei Kushiro, Satoshi Watanabe, Yuka Goto, et al.
ESC Heart Failure|September 21, 2021
Phenomapping in patients experiencing worsening renal function during hospitalization for acute heart failureRyuichiro Yagi, Makoto Takei, Shun Kohsaka, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 5, 2015
Critical Roles of Chemoresistant Effector and Regulatory T Cells in Antitumor Immunity after Lymphodepleting ChemotherapyYu Saida, Satoshi Watanabe, Tomohiro Tanaka, et al.
Pageof 11

Showing results (81-90 of 109) with videos related to

Sort By:
Pageof 11
American Journal of Preventive Cardiology|January 29, 2025
Achievement of guideline-based lipid goals among very-high-risk patients with atherosclerotic cardiovascular disease and type 2 diabetes: results in 213,380 individuals from the cvMOBIUS2 registrySatoshi Shoji, Nishant P Shah, Peter Shrader, et al.
JAMA Network Open|January 14, 2025
Electronic Patient-Reported Outcome System Implementation in Outpatient Cardiovascular Care: A Randomized Clinical TrialShuhei Yamashita, Yoshinori Katsumata, Shun Kohsaka, et al.
Oncology|February 15, 2018
A Phase II Study of Irinotecan for Patients with Previously Treated Small-Cell Lung CancerRie Kondo, Satoshi Watanabe, Satoshi Shoji, et al.
European Journal of Heart Failure|July 4, 2025
Residual pulmonary hypertension and clinical outcomes in acute decompensated heart failure patients stratified by left ventricular ejection fractionToshikazu D Tanaka, Yasuyuki Shiraishi, Ryeonshi Kang, et al.
International Journal of Cardiology|April 14, 2022
Conventional medical therapy in heart failure patients eligible for the PARADIGM-HF, DAPA-HF, and SHIFT trialsSatoshi Shoji, Shun Kohsaka, Yasuyuki Shiraishi, et al.
Circulation. Heart Failure|January 26, 2018
Percutaneous Occlusion of Patent Ductus Arteriosus for an Elderly Patient With Refractory Congestive Heart FailureSatoshi Shoji, Hideaki Kanazawa, Ryo Yanagisawa, et al.
Journal of Atherosclerosis and Thrombosis|March 4, 2026
Cardiovascular Risk of Alcohol Consumption due to Renal Impairment: A 10-Year Prospective Study in a Community-Dwelling Japanese PopulationAya Hirata, Sei Harada, Miho Iida, et al.
Translational Lung Cancer Research|October 17, 2022
Efficacy and safety of amrubicin therapy after chemoimmunotherapy in small cell lung cancer patientsKohei Kushiro, Satoshi Watanabe, Yuka Goto, et al.
ESC Heart Failure|September 21, 2021
Phenomapping in patients experiencing worsening renal function during hospitalization for acute heart failureRyuichiro Yagi, Makoto Takei, Shun Kohsaka, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 5, 2015
Critical Roles of Chemoresistant Effector and Regulatory T Cells in Antitumor Immunity after Lymphodepleting ChemotherapyYu Saida, Satoshi Watanabe, Tomohiro Tanaka, et al.
Pageof 11